TMEM2 induces epithelial-mesenchymal transition and promotes resistance to temozolomide in GBM cells
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 23 references indexed in Scilit:
- TMEM2: A missing link in hyaluronan catabolism identified?Matrix Biology, 2019
- Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cellsJournal of Experimental & Clinical Cancer Research, 2019
- Comparison of glioblastoma (GBM) molecular classification methodsSeminars in Cancer Biology, 2018
- LinkedOmics: analyzing multi-omics data within and across 32 cancer typesNucleic Acids Research, 2017
- TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomasJournal of Experimental & Clinical Cancer Research, 2017
- HIT'nDRIVE: patient-specific multidriver gene prioritization for precision oncologyGenome Research, 2017
- EMT and inflammation: inseparable actors of cancer progressionMolecular Oncology, 2017
- GlioVis data portal for visualization and analysis of brain tumor expression datasetsNeuro-Oncology, 2016
- TMEM2 Is a SOX4-Regulated Gene That Mediates Metastatic Migration and Invasion in Breast CancerCancer Research, 2016
- Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugsJournal of Enzyme Inhibition and Medicinal Chemistry, 2016